Search fresh public links, source activity, and ready-to-use post angles for Glp-1 Drug Prices.
Fresh curated links around GLP-1 Drug Prices are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
For Americans who have been priced out of popular weight-loss medications, a $149 monthly price tag sounds like welcome news. After years of seeing drugs...
For years, the price tag has been one of the biggest barriers to GLP-1 medications like Ozempic and Wegovy. That is starting to change, though not in the same way for everyone....
WEDNESDAY, Aug. 26, 2026 — In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn’t afford the $750 monthly price tag. “I thought, ‘T...
Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths t...
As GLP-1 telehealth demand remains high in 2026, this MEDGm review takes a closer look at the brand-stated $169 starting price, compounded semaglutide and tirzepatide options, bran...
By JOHN SAMARAS A US retail pharmacy pays $1,302 to acquire one month of branded Wegovy. That figure comes from the Centers for Medicare and Medicaid Services National Average Drug...
Approximately one in eight U.S. adults is currently taking a GLP-1 drug. Usage is reshaping one of the country’s biggest industries.
In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn’t afford the $750 monthly price tag.
The experimental drug is not FDA-approved, and its biologic classification could shape when lower-cost competitors reach patients if regulators approve it.
Medicare launched a pilot program that could streamline the process to get GLP-1s, with some seniors paying just $50 a month. But many people with the most serious illnesses won't...
The research provides valuable insights into GLP-1 drug pricing and highlights the importance of transparent, reliable data in helping consumers better understand healthcare costs....
Novo Nordisk said Tuesday that it will pay Hengrui Pharma up to $2.6 billion for the right to market a GLP-1 weight loss pill that patients could potentially take just once per wee...
The notice adds to growing concerns about the safety of knockoff weight loss drugs, which have remained popular despite FDA warnings and legal pressure from Eli Lilly and Novo.
As Medicare's GLP-1 Bridge program gets underway in earnest and questions remain about the long-term use of these drugs, Eli Lilly is offering a new look at how older adults fare o...
Overall drug costs in Canada rose 9.5 per cent in 2025 compared to 2024, a new report by private insurance company GreenShield said.
Twenty-two vials of compounded tirzepatide are affected, and the pharmacy had an FDA warning letter on sterility problems before the recall.
There is a lot going on in the GLP-1 space, a market that landed $79 billion last year, and could shift significantly in the coming years. The post Beyond Ozempic: the GLP-1 landsc...
Finally, Some Evidence Employers Can Use to Justify Covering GLP-1s Anonymous (not verified) Thu, 08/27/2026 - 09:40 pharmagather item url Finally, Some Ev...
Plan sponsors pushback on cost drivers, PBM evaluation a crucial calling card for benefits brokers
Employer health costs are projected to spike in the upcoming year, forcing many companies that recently expanded coverage of GLP-1 drugs to reverse course.
Mounjaro recorded sales of ₹1,256 crore in the 12 months ending August 2026, up 502 per cent from the previous year
A new pancreatic cancer drug is carrying a price tag that may shock you -- $480,000 per year. Most consumer products are priced to recover R&D and production costs, plus a reas...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.